Related Experiment Video
Updated: Aug 9, 2026
14:28
Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
Summary
Preliminary results for AIDSVAX (Acquired Immunodeficiency Syndrome Vaccine) showed disappointing outcomes in a large trial. However, some interesting findings emerged within a small group of non-white participants, suggesting potential subgroup efficacy.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- The development of an effective vaccine against the Human Immunodeficiency Virus (HIV) remains a critical global health priority.
- AIDSVAX was an early candidate vaccine investigated for its potential to prevent HIV infection.
Purpose of the Study:
- To evaluate the efficacy and safety of AIDSVAX in a large-scale clinical trial.
- To identify any potential demographic or subgroup differences in vaccine response.
Main Methods:
- A large-scale, placebo-controlled clinical trial was conducted to assess AIDSVAX.
- Data were presented preliminarily, including subgroup analyses based on participant demographics.
Main Results:
- Overall trial results were reported as disappointing, indicating a lack of significant protective effect in the general study population.
- Intriguing preliminary findings suggested a potential differential response among a small cohort of non-white volunteers.
Conclusions:
- The large-scale trial of AIDSVAX did not meet primary efficacy endpoints.
- Further investigation is warranted to explore the observed preliminary signals in specific subpopulations.
More Related Videos
13:36Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
09:12Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol
Published on: April 5, 2024
Related Concept Videos
01:51Vaccinations
Overview
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:26Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...